Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.